FUJIFILM Diosynth Biotechnologies

This week, our California team embraced the holiday spirit with an Ugly Sweater Party, bringing festive fun and creativity to the workplace! 🎉🎅 The event was a wonderful opportunity for team members to express their holiday cheer and unique style, showcasing an array of vibrant and playful sweaters. Beyond the laughter and style statements, these gatherings strengthen our sense of community and fellowship, which are essential to the collaborative and innovative culture we cherish. Here's to a joyful holiday season filled with camaraderie and shared success! #HolidayCheer #TeamSpirit

Every hour of every day, employees at our facilities in the US (California, Texas and North Carolina), UK, Denmark and Japan are on a mission to bring medicines to patients faster.   Our roadmap through 2028 will see us expand our existing manufacturing capabilities and capacities in Holly Springs, College Station, Billingham, Hillerød and Toyama, replicating the same proven technology, facility designs, equipment, processes and procedures. We call this manufacturing ecosystem kojoX. With kojoX, we’re transforming biopharmaceutical manufacturing for the good of the customer and the patient. Every expansion we add to our current network not only increases our global manufacturing capacity, it also provides quicker turnaround times and scalability -- no matter the location. As Partners for Life, we’re here to offer quality and consistency, bringing lifesaving medicines to patients faster, around the globe. https://lnkd.in/d97zix6W #PharmaManufacturing #HealthcareInnovation #LifeSciences #GlobalHealth #SupplyChainManagement

Did you know that Fujifilm Diosynth Biotechnologies is manufacturing in 4 different countries across the globe? Well, you do now. Across the US, UK, Denmark and Japan, we work every day to produce medicines for patients faster and with the same high level of quality, reliability, and efficiency at every facility. Across these strategic locations, we are transforming the industry by adding capacity while standardizing proven technologies and ways of working. We call this “kojoX”. With kojoX we harmonize facility designs, equipment, processes, and procedures across our network to increase speed and at the same time ensure consistency, quality and scalability in biomanufacturing. Our first capacity expansion in Denmark came online in 2024. Next milestone is completion of the first phase of our facility in Holly Springs, North Carolina. Here we are set to go live in 2025. But it doesn’t stop there. With more than $8bn invested, we will continue to bring capacity online and with kojoX we’re committed to delivering change for the good of the customer and the patient. Learn more on our website: https://lnkd.in/fk_JkdJ

We’ve got what it takes to build one of the largest end-to-end cell culture contract manufacturing facilities in North America. 🧫🔬 As the first phase of our FUJIFILM Diosynth Biotechnologies Holly Springs, North Carolina, site nears operational status, our collaboration with Jacobs Life Sciences Vice President and General Manager, Dana Tilley, alongside FUJIFILM Diosynth Biotechnologies' Vice President of Project Delivery, Jordan Ulrich, is spotlighted in BioPharm International. Together, they discuss how modularization and digital delivery strategies are revolutionizing pharmaceutical manufacturing. These innovative tools help contract development and manufacturing organizations achieve scalability, flexibility, safety, and sustainability goals. ✅ Discover how this cutting-edge approach accelerates patient access to new and emerging treatments. ⬇️ https://lnkd.in/e3q_n5hJ? #CDMO #Medicine #LifeSciences #Manufacturing

As we kicked off the holiday season, our Holly Springs team embraced the festive spirit with an Ugly Christmas Sweater event and a Gingerbread House Making competition. 🎄🎉 These events were more than just fun—they were a testament to the creativity and camaraderie that define our workplace culture. Fueled by friendly competition and festive cheer, our team members showcased their exceptional creativity and teamwork. The joy and laughter shared during these activities not only reinforced our bonds but also reflected the positive energy that drives us in our mission to innovate and excel. Wishing everyone a cheerful start to the holiday season! Here’s to a season filled with warmth, success, and infinite possibilities. #HolidaySpirit #TeamCelebration #CorporateCulture

When we first broke ground on our planned global biomanufacturing hub in Holly Springs, NC back in 2022, the completion of the site felt impossibly far away. Now, 2 years later, we’re excited to show off what you can expect when it comes online in 2025. As the largest and most flexible biomanufacturing plant in the US, Holly springs will feature 8 x 20,000 L bioreactors up and running at launch, with an additional 8 x 20,000 L bioreactors online in 2028. This $3.2bn project is a testament to the power of our kojoX approach, which means that we replicate the same proven technology, facility designs, equipment, processes and procedures – guaranteeing quality and speed, no matter the location.  In this case between Holly Springs, US and our facility in Hillerød, Denmark. KojoX guarantees that patients receive the same high-quality product, regardless of where it is manufactured. Want to see inside? https://lnkd.in/eDEMEsyT

Our Hillerød site recently welcomed 30 of our cutest-ever visitors—babies under the age of 1—along with their parents! The Danish team hosted an event for a professional parental leave network, which supports parents in Denmark during their leave—often up to a year—helping them stay inspired and connected to their work life as they prepare to return. The event included an engaging talk on using futurism in organizations, offering practical ideas and insights for everyone involved. It was a wonderful reminder of how career growth and family life can go hand in hand, with our smallest guests adding a special energy to the day. Thank you to all the parents and babies for visiting us—it was a pleasure to host you! #WorkLifeBalance #ParentalLeave #CareerAndFamily

We’re excited to announce that FUJIFILM Diosynth Biotechnologies will be attending JPM Week 2025 in San Francisco from January 13-16! This annual gathering is a cornerstone of the biotech and pharma industry, bringing together innovators, leaders, and partners to shape the future of healthcare. We’re looking forward to connecting, sharing our vision, and exploring opportunities to advance life-changing therapies. #JPMWeek2025 #Biotechnology #Pharma #Innovation #JPMWeek #BiotechConference #LifeSciences #Pharmaceuticals #PharmaIndustry

Want to learn more about our efforts to create a better world for both today's patients and tomorrow's generations to come? Check out our sustainability report to learn more 🌳

Last week, we had the pleasure of welcoming 16 PhD students from the Centre of Excellence in Bioprocessing, a collaboration between FUJIFILM Diosynth Biotechnologies and the The University of Edinburgh, University of York, and The University of Manchester. The day was filled with networking, knowledge sharing, and meaningful conversations—a fantastic opportunity for students and staff alike to connect and learn from one another. This annual event is something we look forward to every year, as it highlights the power of collaboration in advancing bioprocessing innovation and supporting the next generation of industry leaders. Thank you to everyone who participated and made this a truly inspiring day! #Bioprocessing #PhDStudents #Collaboration #BiotechInnovation #Research